Heron Therapeutics, Inc. /De/ (HRTX)10% owner bought ~$3.58M

~$3.58M

Approx. value · 2.39M sh @ $1.50

29.1M

Holds after · shares reported

Traded

Aug 8, 2025

Filed

Aug 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 8, 2025 · this disclosureInsider10% owner purchased ~$3.58M of HRTX shares in the open market

What came next

1. Aug 8, 2025InsiderDirector purchased ~$2.65M of HRTX shares in the open market
2. Oct 27, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 27, 2025, the Board of Directors (the “Board”) of Heron Therapeutics, Inc. (the “Company”) appointed Thomas Cusack to the Board to serve for a term expiring at the Company’s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.”
3. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Heron Therapeutics, Inc. /De/

OQRO holds no insider, Congress, fund or contract record for Heron Therapeutics, Inc. /De/ dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HRTX page.

Other recent filings by Rubric Capital Management LP, 10% owner

• SEC Form 4 at Collegium Pharmaceutical, Inc. (COLL)Aug 15, 2025
• SEC Form 4 at Talen Energy (TLN)Jun 27, 2025
• SEC Form 4 at Talen Energy (TLN)Jun 27, 2025
• SEC Form 4 at Talen Energy (TLN)Jun 27, 2025
• SEC Form 4 at Talen Energy (TLN)Jun 27, 2025

The full history of Rubric Capital Management LP, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Heron Therapeutics, Inc. /De/

• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 4Aug 12, 2025
• SEC Form 13F-HRNov 14, 2024
• House Clerk periodic transaction reportApr 5, 2021

Everything OQRO holds on this company is on its HRTX page.